EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics

Chenxuan Zang iD, Charles C Guo, Yaohong Wang, Peng Wei, Ziyi Li iD

PLOS Computational Biology · 2026

DOI: 10.1371/journal.pcbi.1014058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Chenxuan Zang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Hauptthemen laut MEDLINE: Neoplasms, Gene Expression Profiling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of tumor cells is pivotal for understanding tumor heterogeneity and the tumor microenvironment. Recent advances in spatially resolved transcriptomics (SRT) have revolutionized the way that transcriptomic profiles are characterized and have enabled the simultaneous quantification of transcript locations in intact tissue samples. SRT is a promising alternative method to study gene expression patterns in spatial domains. Nevertheless, the precise detection of tumor regions within intact tissue remains a great challenge. A common strategy for identifying tumor cells is via tumor-specific marker gene expression signatures, which are highly dependent on marker accuracy. Another effective approach is through aneuploid copy number alterations, as most types of cancer exhibit copy number abnormalities. Here, we introduce a novel computational method, called TUSCAN (TUmor Segmentation and Classification ANalysis in spatial transcriptomics), which constructs a spatial copy number variation profile to improve the accuracy of tumor region identification. TUSCAN combines gene information from SRT data and hematoxylin-and-eosin-staining image to annotate tumor sections and other benign tissues. We benchmark the performance of TUSCAN and several existing methods through the application to multiple datasets from different SRT platforms. We demonstrate that TUSCAN can effectively delineate tumor regions, with improved accuracy compared to other approaches. Additionally, the output of TUSCAN provides interpretable clonal evolution inferences that may lead to novel insights into disease development and potential druggable targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGene Expression ProfilingSpatial TranscriptomicsHumansComputational BiologyDNA Copy Number VariationsAlgorithmsClassification AlgorithmsTumor MicroenvironmentTranscriptomeBiomarkers, Tumor

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

ORCID-Profile: Chenxuan Zang, Ziyi Li

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Zang, C., Guo, C. C., Wang, Y., Wei, P., & Li, Z. (2026). TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014058

Vancouver

Zang C, Guo CC, Wang Y, Wei P, Li Z. TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014058

BibTeX
@article{Zang2026,
  author = {Zang, Chenxuan and Guo, Charles C and Wang, Yaohong and Wei, Peng and Li, Ziyi},
  title = {TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics},
  journal = {PLOS Computational Biology},
  year = {2026},
  doi = {10.1371/journal.pcbi.1014058}
}
Kostenlos starten →